The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.
Converting From Manual to Electronic Transactions Could Save Healthcare Industry Billions
September 4th 2014A report issued by the Council for Affordable Quality Healthcare (CAQH) suggests that if providers and health plans converted fully from manual to electronic transactions, it could result in an additional estimated savings of $8.1 billion for the healthcare industry.
FDA Approval Sought for Lenvatinib in Differentiated Thyroid Cancer
August 31st 2014Eisai has submitted a New Drug Application for lenvatinib (E7080) as a treatment for patients with progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC), based on findings from the phase III SELECT trial that was presented at the 2014 ASCO Annual Meeting.
Report Identifies Shortfalls in Medicare Accountability Model
August 25th 2014How much physicians get paid is increasingly determined by a payment formula that penalizes doctors whose patients are more expensive-even when those higher costs stem from services that other doctors perform says a new report from the Center for Healthcare Quality and Payment Reform.
Using Technology to Improve Patient Fee Collection Rates
August 19th 2014Although the Affordable Care Act (ACA) made accessibility to health insurance easier, consumers are finding themselves shouldering greater out-of-pocket costs in the form of copayments and deductibles for the care that they receive. Physicians are also feeling the need to collect more fees from more of their patients.
Medicaid and Uninsured Patients More Likely to Present With Advanced Disease
August 15th 2014Patients with Medicaid insurance and those without insurance were more likely to present with distant disease than patients with private insurance, according to results presented in the Journal of Clinical Oncology.
First-Year Results Reported for Michigan Oncology Medical Home Pilot Program
August 12th 2014A multipractice oncology medical home model, the Michigan Oncology Medical Home Demonstration Project (MOMHDP), reported preliminary first-year results that tallied an estimated savings per patient of $550.33, according to an abstract in the Journal of Oncology Practice.
FDA Expands Bortezomib Multiple Myeloma Label
August 11th 2014The FDA has expanded the bortezomib (Velcade) label to allow for retreatment in patients with multiple myeloma who previously responded to the proteasome inhibitor, according to an announcement made by Millennium/Takeda, the companies that manufacture the drug.
CMS Shuts Down Pharma Payment Verification System
August 8th 2014The Centers for Medicare & Medicaid Services (CMS) took down its Web site that verifies payments from pharmaceutical companies to physicians, after at least 1 doctor had payments attributed to him that were actually made to someone else.
California Bundled Payment System Fails to Take Hold
August 5th 2014A regional bundled payment system has hit a roadblock in California, according to a study in Health Affairs. The program failed to meet its goals, succumbed to recruitment challenges, faced regulatory uncertainty, and sputtered under administrative burdens.